Orthologic News (NASDAQ:OLGC)
| Latest Orthologic News Headlines | | Date | Time | Source | | | 12/11/2006 | 9:00AM | PRNUS | Studies of OrthoLogic's Chrysalin(R) (TP508) Show Specific Receptor Binding Activity and Effects in Human Endothelial Cells
SAN DIEGO, Dec. 11 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced results of experiments that advance the basic science supporting its novel synthetic peptide Chrysalin (TP508). Two posters are being presented at the American Society for Cell Biology 46th Annual Meeting in San Diego, CA (December... More...>> |
| 11/02/2006 | 4:00PM | PRNUS | OrthoLogic Announces Third Quarter 2006 Financial Results
TEMPE, Ariz., Nov. 2 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced financial results for the third quarter of 2006.
OrthoLogic reported a net loss of $5.8 million, or $0.14 per share, for the third quarter of 2006, compared to a net loss of $7.6 million or $0.20 per share, for the third quarter... More...>> |
| 10/26/2006 | 4:00PM | PRNUS | OrthoLogic to Host Conference Call Discussing Third Quarter 2006 Results
TEMPE, Ariz., Oct. 26 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for the third quarter ending September 30, 2006, on Thursday, November 2, 2006.
Management will host a conference call and webcast the same day at 4:30 PM EST (2:30 PM... More...>> |
| 08/29/2006 | 4:00PM | PRNUS | OrthoLogic Announces Results of Preliminary Interim Analysis of Phase 2b Clinical Trial of Chrysalin(R) (TP508) in Fracture Rep
TEMPE, Ariz., Aug. 29 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced results of an interim analysis of data from its Phase 2b dose-ranging clinical trial of the novel synthetic peptide Chrysalin(R) (TP508) in unstable, displaced distal radius (wrist) fractures.
Study Description
This was... More...>> |
| 08/09/2006 | 4:00PM | PRNUS | OrthoLogic Announces Second Quarter 2006 Financial Results
TEMPE, Ariz., Aug. 9 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced financial results for the second quarter of 2006.
OrthoLogic reported a net loss of $6.5 million, or $0.16 per share, for the second quarter of 2006, compared to a net loss of $6.6 million or $0.17 per share, for the second... More...>> |
| 08/09/2006 | 7:45AM | PRNUS | Reminder - OrthoLogic to Host Conference Call Discussing Second Quarter 2006 Results
TEMPE, Ariz., Aug. 9 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for the second quarter ending June 30, 2006, on Wednesday, August 9, 2006.
Management will host a conference call and webcast the same day at 4:30 PM EDT (1:30 PM MT... More...>> |
| 08/02/2006 | 10:12AM | PRNUS | OrthoLogic to Host Conference Call Discussing Second Quarter 2006 Results
TEMPE, Ariz., Aug. 2 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for the second quarter ending June 30, 2006, on Wednesday, August 9, 2006.
Management will host a conference call and webcast the same day at 4:30 PM EDT (1:30 PM MT... More...>> |
| 05/04/2006 | 8:00AM | PRNUS | OrthoLogic Announces First Quarter 2006 Financial Results
TEMPE, Ariz., May 4 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced financial results for the first quarter of 2006.
OrthoLogic reported a net loss of $16.5 million, or $0.42 per share, for the first quarter of 2006, compared to a net loss of $5.5 million and $0.14 per share for the first quarter... More...>> |
| 04/27/2006 | 9:00AM | PRNUS | OrthoLogic to Host Conference Call Discussing First Quarter 2006 Results
TEMPE, Ariz., April 27 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for 1Q2006 on Thursday, May 4, 2006.
Management will host a conference call and Webcast the same day at 9:00AM EDT (6:00AM MT). The call may be accessed at 866-825-1692... More...>> |
| 04/06/2006 | 9:00AM | PRNUS | OrthoLogic Announces Management Update
TEMPE, Ariz., April 6 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced the resignation of James M. Pusey, MD as President and CEO. Dr. Pusey has decided to pursue other opportunities.
John M. Holliman, III, a director of OrthoLogic since September 1987 and Chairman of the Board of Directors... More...>> |
| 03/15/2006 | 7:00AM | PRNUS | OrthoLogic Announces Results of Phase 3 Clinical Trial of Chrysalin(R) (TP508) in Fracture Repair
TEMPE, Ariz., March 15 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced results of an analysis of topline data from its Phase 3 clinical trial of the novel synthetic peptide Chrysalin(R) (TP508) in unstable, displaced distal radius (wrist) fractures. Treatment with 10ug Chrysalin did not demonstrate... More...>> |
| 03/07/2006 | 8:30AM | PRNUS | OrthoLogic Updates Guidance for Release of Phase 3 Results for Chrysalin(R) in Fracture Repair
TEMPE, Ariz., March 7 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced revised guidance for the expected release of topline results from its Phase 3 clinical trial of Chrysalin(R) (TP508) in fracture repair. Management now expects to communicate topline results by March 31, 2006, which is revised... More...>> |
| 02/28/2006 | 6:00AM | PRNUS | OrthoLogic Announces Alliance With Quintiles to Develop Chrysalin
Alliance Designed to Accelerate Global Development of Lead Clinical Program
TEMPE, Ariz., Feb. 28 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced the formation of a strategic alliance with Quintiles, the world's leading pharmaceutical services organization, to develop and commercialize Chrysalin(R... More...>> |
| 02/24/2006 | 7:26AM | PRNUS | OrthoLogic Announces Acquisition of New Class of Molecules, ICARMs(TM)
Company Expands and Diversifies Product Portfolio
TEMPE, Ariz., Feb. 24 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today it has agreed to acquire certain assets and assume certain liabilities of AzERx Inc. (AzERx) for $390,000 cash and the issuance of 1,355,000 shares of OrthoLogic common stock... More...>> |
| 02/13/2006 | 9:37AM | PRNUS | OrthoLogic Appoints William M. Wardell, MD, PhD, to Board of Directors
TEMPE, Ariz., Feb. 13 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today the appointment of William M. Wardell, M.D., Ph.D., to its Board of Directors.
Dr. Wardell owns and operates the consulting firm Wardell Associates International LLC in Princeton, NJ, where he specializes in drug development... More...>> |
| 02/08/2006 | 10:08AM | PRNUS | BIO CEO & Investor Conference 2006 to Webcast OrthoLogic Presentation
TEMPE, Ariz., Feb. 8 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that management will provide an overview of the Company and its lead compound for tissue and bone healing, Chrysalin(R) (TP508), at the BIO CEO Investor Conference 2006. The presentation will be delivered at 11:30 a.m. EST... More...>> |
| 01/31/2006 | 4:01PM | PRNUS | OrthoLogic Reports Fourth Quarter and Full-Year 2005 Results
- Company Sharpens Focus on Lead Development Programs With Top-line Phase 3 Results Expected by April 30, 2006 -
TEMPE, Ariz., Jan. 31 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced financial results for the fourth quarter and full-year ended December 31, 2005.
OrthoLogic reported a net loss... More...>> |
| 01/24/2006 | 4:00PM | PRNUS | OrthoLogic to Webcast Conference Call Discussing Fourth Quarter and Full-Year 2005 Financial Results on January 31, 2006
TEMPE, Ariz., Jan. 24 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for the fourth quarter and full-year of 2005 on Tuesday, January 31, 2006 after the U.S. markets close.
Management will host a conference call and webcast the same day... More...>> |
| 01/11/2006 | 8:00AM | PRNUS | OrthoLogic Appoints Les Taeger Chief Financial Officer
TEMPE, Ariz., Jan. 11 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) today announced the appointment of Les Taeger to the position of Senior Vice President and Chief Financial Officer, effective January 16, 2006. Mr. Taeger joins OrthoLogic from Cardiotech International, and its predecessor Gish Biomedical... More...>> |
| 11/22/2005 | 9:44AM | PRNUS | The Wall Street Analyst Forum's 17th Annual Analyst Conference to Webcast OrthoLogic Presentation
TEMPE, Ariz., Nov. 22 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that management will provide an overview of the Company and its lead compound for tissue and bone healing, Chrysalin(R), at The Wall Street Analyst Forum's 17th Annual Analyst Conference. The presentation will be delivered... More...>> |
|
|
|